BACKGROUND:Adolescence is a key developmental stage marked by physiological and behavioural changes. Eating behaviour, modifiable and sex-dependent, may be altered and linked to future health issues. This cross-sectional study aims to assess whether eating behaviours and body composition are associated in an adolescent sample. METHODS:Participants aged 12.5-17.5 years were recruited from 10 European cities, with valid data on age, sex, socio-demographic status, body composition and physical activity and who had also completed the specific eating behaviour questionnaire "Eating Behaviour and Weight Problems Inventory for Children". Different linear regression models were adjusted for relevant confounders, and ANCOVA models were performed. RESULTS:Eating Behaviours related to weight concerns, dietary restraint, emotional eating, fear of weight gain, healthy nutrition and figure dissatisfaction were strongly positively associated with higher Body Mass Index (BMI), Fat Mass Index (FMI) and Waist Circumference (WC), especially in males (betas resulting from the association between these behavioural subscales and body composition in males, ranged from 0.174 to 0.974 for BMI, 0.172 to 0.930 for FMI, and 0.128 to 0.889 for WC). The strongest association was detected in the weight concerns subscale for both males and females. CONCLUSION:Eating behaviours across all domains are significantly linked to body composition, with variations depending on the specific behavioural domain and the adolescent's sex. These findings are critical for identifying specific behavioural patterns that contribute to obesity and related health issues, providing new insights for more targeted prevention strategies during this crucial stage of development.

The consumption of low-alcohol fermented beverages has been related to cardiovascular health improvements. Although the underlying mechanism is not completely understood, (poly)phenols have been proposed as one of the mediators. The objective of this study was to evaluate the impact of a controlled intervention with beer on (poly)phenols metabolism in individuals with and without metabolic syndrome (MetS). 20 participants (MetS and control) who consumed a standardized amount of beer during 6 weeks were recruited. Phenolic compounds were assessed in urine. Different changes in phenolic compounds associated with chronic beer consumption were found, particularly related to hesperetin conjugates and to the degradation of phenolic compounds derived from flavonoids and lignans. Noteworthily, MetS and control participants differed in baseline urine phenolic compound profiles and in their metabolization. Significant differences were found in the production and excretion of key (poly)phenols-derived metabolites, such as increased naringenin phase II conjugates in healthy subjects, or increased bacterial flavonoid catabolites. Certain relationships were observed between the phenolic compounds with metabolic and anthropometric variables. These findings suggest that beer-derived (poly)phenols are differentially metabolized according to metabolic-health status, and that they may contribute to certain metabolic health benefits through the modulation of specific metabolic pathways.

SummaryBackgroundAlthough the genetic interplay with the environment has a major impact on obesity development, little is known on whether breastfeeding could modulate the genetic predisposition to obesity.ObjectivesTo investigate whether breastfeeding attenuates the effect of an obesity genetic risk score (GRS) on adiposity in European adolescents.MethodsTotally 751 adolescents from the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) cross‐sectional study were included, divided according to breastfeeding status into never breastfed, 1–3 months and ≥4 months. Adjusting by socioeconomic status and lifestyle factors multiple linear regression models were used to assess (1) the main effect of breastfeeding duration and (2) its interaction effect with an obesity GRS, to predict different adiposity measures.ResultsA significant negative association between ≥4 months of breastfeeding and waist circumference (WC) z‐score was observed [β (95% confidence interval), p‐value] = [β = −0.189 (−0.37, −0.00), p = 0.044]. Also, significant interaction effects were observed for 1–3 and ≥4 months of breastfeeding and obesity GRS regarding body mass index (BMI) z‐score [β = 0.155 (0.06, 0.24), p = 0.001] and [β = 0.108 (0.01, 0.18), p = 0.020, respectively] and fat mass index (FMI) z‐score [β = 0.134 (0.04, 0.22), p = 0.003] and [β = 0.100 (0.01, 0.18), p = 0.026, respectively].ConclusionsBreastfeeding modulates the association between the obesity GRS and body composition in adolescents.

Objective This study evaluated the effects of filtered, alkalinized water on inflammation and intestinal dysbiosis in individuals with inflammatory bowel disease (IBD). Methods We conducted a three-month, two-arm, randomized intervention study involving 46 patients with IBD in remission. Participants were divided into two groups: one consumed filtered water from an active filtering device, and the control group consumed water from a mock device. Blood and stool samples were collected before and after the intervention. We assessed antioxidant capacity and circulating cytokine levels from plasma. Gene expression levels of inflammatory mediators were determined using mRNA from peripheral blood mononuclear cells (PBMCs). The microbial composition of fecal samples was characterized by qPCR analysis using primers targeting 16S rRNA genes. Results Consumption of alkalinized filtered water significantly reduced IL1B gene expression in PBMCs. Furthermore, subjects drinking alkalinized filtered water exhibited a consistent, albeit not statistically significant, decrease in circulating IL-1β and significantly lower levels of IL-4 than controls. Microbiome analysis revealed that the levels of the Bacteroides fragilis Group were significantly lower in subjects consuming tap water than in those consuming filtered water. Conclusion These changes suggest that consuming alkalinized water for three months leads to an improved inflammatory status compared with consuming tap water. ### Competing Interest Statement The authors have declared no competing interest. Alkanatur, 050501200065 Ministerio de Ciencia, Innovación y Universidades, PID2021-122765OB-I00 European Innovation Council, GA-101162517

This study evaluated the intestinal effects of alkalinized filtered water in lean and obese adult Zucker rats. For 3 months, 12-week-old rats consumed either tap water or filtered alkalinized tap water from Madrid city. Weight gain was monitored, changes in metabolism were evaluated by indirect calorimetry, and total antioxidant capacity and levels of inflammatory mediators were measured in plasma. Feces were collected, their microbial composition was analyzed and histological analysis of the small and large intestine was performed, assessing the general state of the mucosa (MUC2), the inflammatory state (F4/80) and the presence of oxidative modifications in protein 4-Hydroxynonenal (4-HNE) by immunofluorescence (IF) and immunohistochemistry (IHC). The results obtained showed that the consumption of alkalinized filtered water improved the composition of the intestinal microbiome and the state of the intestinal mucosa, reducing both local and systemic inflammation and the level of oxidative stress. These changes were accompanied by a better maintenance of the oxidative status in rats. No differences were observed in antioxidant capacity nor in weight gain. The incorporation of probiotics in the diet had a significant impact on the microbiome. These effects were indicative of an improvement in general metabolic, oxidative and inflammatory status.

Background and objectives: The gut microbiota performs many functions in the host organism, and metabolites derived from its activity, such as short-chain fatty acids (SCFA), are involved in immunometabolism. Alterations in gut microbial composition play an essential role in diseases such as heart failure, kidney disease, obesity, and diabetes mellitus. The current work aimed to analyze the associations of serum and fecal inflammatory biomarkers with the microbiota and SCFA in prediabetic subjects. Methods: 65 prediabetic patients, diagnosed according to the American Diabetes Association criteria, who participated in a randomized controlled intervention study with Moringa oleifera Lam. (2.4 g/day), were included. Inflammatory markers (Serum C reactive protein [CRP] and fecal calprotectin and sIgA), gut microbiota (qPCR), and short-chain fatty acids (SCFA; GC-FID) were studied before (V0) and after a 12-week intervention (V12). Relationships were explored using principal component analysis (PCA). Lineal regression models were performed to determine the predictive variables of inflammatory markers by including SCFA and gut microbiota groups as one block of independent variables. Fat mass percentage (BIA) and treatment group were used to adjust the models. Analyses were performed for V0 and V12 separately. Results: Only for calprotectin were significant models found at V0 (p = 0.044) and V12 (p = 0.010). Lactobacillus (standardized beta, β= 0.292; p = 0.047) and Bacteroides (β = 0.430; p = 0.009) groups were significant predictors at V0 and Lactobacillus (β = 0.339; p = 0.015) and the SCFA valeric acid (β = −0.533; p = 0.014) were predictors of calprotectin in V12. For CRP, a trend was found at V12 regression (p = 0.079), with significant contributions for the Blautia coccoides–Eubacterium rectale group (β = 0.585; p = 0.016) and the categorical binomial variable “Above normal fat mass percentage” (“yes”, “no”) (β = 0.478; p < 0.001). No significant influence of the treatment group was observed. Discussion: Calprotectin levels seem to be dependent on microbiota and SCFA levels. Calprotectin showed a positive and consistent relationship with Lactobacillus spp.; however, its relationships with the Bacteroides group and valeric acid were not consistent and deserve further exploration. CRP and sIgA do not seem to be explained to a significant level by the microbiota and SCFA concentrations in this prediabetic population.

Background/Objectives: The main objective of this study was to examine the association between lifestyle patterns (physical activity, screen and sleep time and diet) and abdominal obesity, and endocrine, metabolic, and immunological biomarkers in adolescents with Down syndrome (DS). Methods: Eighty-three DS adolescents (38.6% girls), aged 11 to 18 years, from the UP&DOWN study were included. Cluster analysis was performed by including the compliance of recommendations of lifestyle variables, such as moderate to vigorous physical activity (MVPA), screen and sleep time and adherence to the Mediterranean diet (AMD). The waist-to-height ratio was used as an indicator of abdominal obesity. Haematological, biochemical and inflammatory biomarkers were analysed. Results: A three-cluster solution was identified: Cluster 1: adolescents with low compliance; Cluster 2: youth with medium compliance; and Cluster 3: adolescents with high compliance. Significant differences in MVPA (p = 0.000), screen time (p = 0.004), sleep time (p = 0.0001), AMD (p = 0.000) and abdominal obesity (p = 0.003) were found. Clusters 2 and 3 had lower levels of triglycerides and LDL-cholesterol than Cluster 1. Cluster 2, in which all adolescents met the MVPA recommendations, had the lowest levels of galactin 3. Conclusions: Compliance with lifestyle recommendations (PA, screen and sleep time and AMD) and the absence of abdominal obesity seem to be associated with better biochemical and inflammatory values.

The EAT-Lancet Commission proposed an evidence-based global reference diet to improve human health within planetary boundaries. Recently, the Planetary Health Diet Index (PHDI) was developed based on the EAT-Lancet recommendations and validated among Brazilian adults. However, the relative validity of the PHDI in adolescents has yet to be assessed. Thus, we aimed to evaluate the relative validity of the PHDI in European adolescents. We used cross-sectional data from 1804 adolescents (12.5–17.5 years) enrolled in the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study. The PHDI (0–150 points) was calculated based on dietary intake data from two non-consecutive 24-h dietary recalls. Associations between the PHDI and usual nutrient intakes, plasma food consumption biomarkers, and adherence to the Mediterranean diet were evaluated using multivariable-adjusted mixed-effects linear regression models. Higher PHDI score was associated with greater intakes of nutrients predominantly from plant-source foods, such as vegetable protein, vitamin E, and folate and with lower intake of nutrients predominately from animal-source foods, such as total and saturated fat, cholesterol, and animal protein. Furthermore, a higher PHDI score was also positively associated with plasma β-carotene, vitamin C, vitamin D, folate, and ferritin concentrations, while negatively associated with trans-fatty acids concentration. Moreover, higher PHDI was related to a greater adherence to the Mediterranean dietary pattern. The PHDI showed good relative validity among adolescents in the HELENA study. Hence, future research should assess adherence to the PHDI and long-term health outcomes.

Background: For the last 25 years, the debate on the benefit–risk balance of moderate alcohol consumption has been ongoing. This study explored the relationships between the pattern of alcohol consumption and subjective quality of life in healthy adults. Material and Methods: Participants were 247 healthy adults aged 25–45 years, with a moderate alcohol consumption, classified in three groups of alcohol intake: None (N = 37; <0.7 g/day), Low (N = 87; 0.7–<5 g/day) and Medium (N = 123; 5–16 g/day in women and 5–28 g/day in men). Information was collected with questionnaires including: alcoholic beverage frequency and pattern, quality of life (SF-36v2), anxiety, depression, health condition, adherence to the Mediterranean diet, physical activity and sleep time. Results: Mean (SD) age of participants was 35.9 (6.3). In the Medium group, the mean alcohol intake was 10.98 ± 4.84 g/day on weekly bases and 24.7 ± 15.2 g/day on weekend days. Beer was the main contributor to total daily alcohol consumption. The percentage of subjects in the Medium group that showed a weekend average intake higher than moderate was 58.5% in exclusively weekend consumers and 48.2% in those who are not exclusive-weekend consumers (p = 0.278). Regarding markers of quality of life and mental health, the results did not show any significant association with alcohol consumption. In conclusion, in subjects that show weekly bases moderate intake of alcohol, weekend-day consumption levels can be high; however, no association of an overall moderate alcohol consumption pattern with quality of life was found.

There is increasing evidence that diet influences the relationship between gut microbiota and individual health outcomes. Nutrient intake affects the composition of the gut microbial community and provides metabolites that influence the host physiology. Dietary patterns, including macronutrient balance and feeding/fasting cycles which may be manipulated with dietary regimens based on caloric restriction periods, influence the gut homeostasis through its impact on the microbial ecosystem. Along the same line, prebiotic and probiotic ingredients and additives in foods, as well as the degree of food processing have consequences on gut microbiota and the related immune and metabolic response of the human host. Acquiring knowledge of these aspects, especially through an -omics-integral approach, might provide the basis for personalized nutritional interventions directed to avoid dysbiosis and contribute to the prevention of major chronic degenerative diseases. Despite vast scientific evidence supporting the relationship between dietary factors and gut microbiota composition and function, the underlying mechanisms and their potential impact are far from clear. There is a lack of well-designed longitudinal studies performed in target population groups whose dietary patterns can be particularly relevant for their future health, as is the case in infants, pregnant women, or athletes.

Different parts of the Moringa oleifera Lam. (MO) tree are consumed as food or food supplements for their nutritional and medicinal value; however, very few human studies have been published on the topic. The current work was aimed to provide ancillary analysis to the antidiabetic effects previously reported in a double-blind, randomized, placebo-controlled, parallel group intervention conducted in patients with prediabetes. Thus, the effect of MO leaves on blood and fecal inflammatory markers, serum lipid profile, plasma antioxidant capacity and blood pressure was studied in participants who consumed 6 × 400 mg capsule/day of MO dry leaf powder (MO, n = 31) or placebo (PLC, n = 34) over 12 weeks. Differences between groups were assessed using each biomarker’s change score with, adjustment for fat status and the baseline value. In addition, a decision tree analysis was performed to find individual characteristics influencing the glycemic response to MO supplementation. No differences in the biomarker’s change scores were found between the groups; however, the decision tree analysis revealed that plasma TNF-α was a significant predictor of the subject’s HbA1c response (improvement YES/NO; 77% correct classification) in the MO group. In conclusion, TNF-α seems to be a key factor to identify potential respondents to MO leaf powder.

Introduction:There is currently a great controversy about the lack of definition regarding the concept of moderate consumption of alcoholic beverages from the point of view of health, since, in turn, it should be a socially accepted consumption. Although still there is not a global agreement about the definition of "moderate consumption", it is considered as such the amount below 10-12 g alcohol/day for women and no more than 20-24g alcohol/day for men. These differences are because that women are not capable as men to metabolise alcohol. According to the scientific evidence, moderate consumption of beer seems to be accepted to maintain an adequate quality of the diet, as it provides vitamins B (vitamin B6, B12 and folates) and minerals (magnesium) among other nutrients, as well as poliphenols and complex carbohydrates. In terms of health, a moderate beer consumption may play a protective role at cardiovascular levels, associated with an enhanced lipid profile. It should be highlighted the possible beneficial effects of a moderate consumption of fermented beverages (such as beer) is associated with other factors, such as gender, age, as well as the pattern of consumption throughout life.

Artificial sweeteners are additives widely used in our diet. Although there is no consensus, current evidence indicates that sucralose and saccharin could influence the gut microbiota. The aim of this study was to analyze the existing scientific evidence on the effects of saccharin and sucralose consumption on gut microbiota in humans. Different databases were used with the following search terms: sweeteners, non-caloric-sweeteners, sucralose, splenda, saccharin, sugartwin, sweet’n low, microbiota, gut microbiota, humans, animal model, mice, rats, and/or in vitro studies. In vitro and animal model studies indicate a dose-dependent relationship between the intake of both sweeteners and gut microbiota affecting both diversity and composition. In humans, long-term study suggests the existence of a positive correlation between sweetener consumption and some bacterial groups; however, most short-term interventions with saccharin and sucralose, in amounts below the ADI, found no significant effect on those groups, but there seems to be a different basal microbiota-dependent response of metabolic markers. Although studies in vitro and in animal models seem to relate saccharin and sucralose consumption to changes in the gut microbiota, more long-term studies are needed in humans considering the basal microbiota of participants and their dietary and lifestyle habits in all population groups. Toxicological and basal gut microbiota effects must be included as relevant factors to evaluate food safety and nutritional consequences of non-calorie sweeteners. In humans, doses, duration of interventions, and number of subjects included in the studies are key factors to interpret the results.

Background. The complexity in the development of an eating disorder (ED) pose methodological challenges when addressing risk factors of this pathology. Pike et al. (2008) proposed to use a case-control design for this type of research. The eating disorders' risk factor study (ANOBAS) is a case-control study with three control groups aiming to evaluate several variables related to the onset of ED, thus the aim was to illustrate a new methodology proposal and to assess whether the chosen control groups are appropriate to research correlates on ED. Methods. We used a case-control design of 50 female adolescents with ED at onset matched by age and their parents' socioeconomic status with 40 patients with an affective disorder, 40 patients with asthma pathology and 50 without pathology. Diagnoses were completed with K-SADS interview and an evaluation of biological, psychological, environmental and family correlates. Results. Higher similarities were found between the ED group and the affective disorder group across psychological variables, whereas the similarities between the ED group and the asthma group were found at the familial level, as we expected. The biggest differences were found with the non-pathology group. Conclusions. This rigorous research design allows investigating correlates associated specifically to the onset of an ED and the chosen control groups are suitable to investigate it.